BioPoint

What BioPoint does

BioPoint Inc. is a private life sciences consulting firm founded in 2011 and headquartered in Peabody, Massachusetts, with a West Coast office in Carlsbad, California. The company delivers specialized consulting and staffing services to pharmaceutical, biotechnology, medical device, and contract research organizations (CROs) across functional areas including drug safety and pharmacovigilance, regulatory affairs, clinical operations and biometrics, clinical development, HEOR/market access, quality assurance/compliance, and medical device regulatory strategy. BioPoint operates three core service models — Functional Service Provider (FSP) partnerships, Staff Augmentation, and Fractional Consultants (engaging former FDA regulators and C-suite specialists on a part-time advisory basis) — delivered through time-and-materials billing, milestone-based SOW engagements, and tiered multi-year contracts. Customer engagement is anchored by an 80+ Life Science client base and a 350+ biotech and pharma partner network, with retention metrics including a 97% project completion rate, 70% contract extension rate, and 81% consultant re-engagement rate.

The business is human-capital-intensive rather than technology-based: BioPoint does not develop proprietary platforms, and revenue is generated by placing vetted consultants into client engagements, not by licensing software. The company markets through a mix of content marketing, LinkedIn presence, industry conference attendance, PR coverage (Inc. 5000, BBJ Fast 50, BioSpace), and — most importantly — a referral-driven consultant network. BioPoint has also built a dedicated AI consulting overlay, advising clients on deploying generative AI for drug discovery, clinical trial design, regulatory submissions, and pharmacovigilance signal detection, though this remains an advisory service rather than a productized technology offering. Headcount is stated at 101–250 employees, and the company has been founder-owned since inception by Edwin Matos, Chris Nash, George Kokoros, Kevin Pike, and Bob DeGroot, with no disclosed private equity or venture capital backing. BioPoint has appeared on the Inc. 5000 list six consecutive years (2015–2020) and the Boston Business Journal Fast 50 in 2015, 2017, and 2021, with revenue growth having decelerated from 5,302% (2011–2014) to 138.73% three-year growth (through 2020) as the company has scaled.

Name

BioPoint

Legal name

BioPoint Inc.

Website

http://www.biopointinc.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

BioPoint Inc. is a private life sciences consulting firm that provides drug safety, regulatory affairs, clinical development, HEOR, and QA staffing and FSP services to 80+ pharmaceutical, biotechnology, and medical device clients through a 350+ consultant network.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Life Sciences & Biotech (R&D/Clinical) Staffing (BPACADAL)

akta.pro secondary industries

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Commercial, Sales & Field Medical (MSL) Staffing FSP (HLAGAOAO)

Keywords

• Life sciences consulting
• Pharmaceutical consulting
• Biotech staffing
• Regulatory affairs services
• Drug safety consulting

Headquarters

HQ city

Peabody

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Consulting and Staffing Services: BioPoint generates revenue by providing specialized consulting services and staffing solutions to pharmaceutical, biotech, and medical device companies. Revenue is derived from placing qualified consultants with clients on a time-and-materials basis, project-based fixed SOW engagements, or Functional Service Provider (FSP) arrangements. The company offers flexible engagement models including just-in-time consulting, fractional consultants, staff augmentation, and full FSP partnerships.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

BioPoint is a life sciences consulting firm that places vetted, specialized consultants with pharmaceutical, biotechnology, and medical device companies across drug safety, regulatory affairs, clinical development, HEOR, quality assurance, and market access functions. The company delivers services via three engagement models — Functional Service Provider (FSP), Staff Augmentation, and Fractional Consultants — under fixed-SOW project, time-and-materials, or milestone-based contracts. With more than 80 Life Sciences clients and 350+ pharma/biotech partner organizations, BioPoint provides just-in-time access to senior life sciences expertise for clients needing scalable, on-demand workforce solutions.

Product overview

BioPoint is a life sciences consulting company offering a portfolio of workforce solutions and specialized consulting services. The core service delivery models include Functional Service Provider (FSP), Staff Augmentation, and Fractional Consultants, which are supported by specialized functional expertise across Drug Safety & Pharmacovigilance, Regulatory Affairs, Clinical Operations & Biometrics, Clinical Development, HEOR, QA & Compliance, Medical Device, Medical Affairs, and Market Access. These services are provided to pharmaceutical, biotech, and medical device companies to accelerate drug development, ensure global regulatory compliance, and optimize market access.

Differentiator

Problem solved

Functional benefit

Products and services

• Functional Service Provider (FSP) A collaborative business model providing specialized consulting services where BioPoint partners with pharmaceutical companies for flexible, scalable functional support across drug safety, regulatory affairs, clinical development, HEOR, and quality assurance functions.
• Staff Augmentation Contingent staffing model delivering qualified professionals for biotech and pharma projects, providing flexible workforce solutions with direct oversight by client hiring managers.
• Fractional Consultants Part-time senior-level expertise from former FDA regulators, C-suite executives, and niche specialists providing advisory and strategic guidance without full-time commitment.
• Drug Safety & Pharmacovigilance Consulting Comprehensive clinical and post-marketed drug safety services including case processing, signal detection, aggregate reports, regulatory consultation, epidemiology, and risk management from preclinical through post-marketing settings.
• Regulatory Affairs Consulting Global regulatory strategy and submissions expertise covering regulatory strategy, CMC, advertising/promotion review, product labeling, medical writing, clinical trial authorizations, and marketing applications.
• Clinical Operations & Biometrics Clinical trial process expertise including project management, clinical research associates, data management, SAS programming, biostatistics, and clinical scientists from protocol development through regulatory submission.
• Clinical Development Consulting Product development support including clinical development strategy, dossiers, submissions, competitive landscape mapping, protocol development, TPP development, and medical monitoring.
• Health Economics & Outcomes Research (HEOR) Consulting Evidence-based business decision support including observational study design, pharmacoeconomic models, PRO instrument development, database studies, global value dossiers, publication strategy, and epidemiological analysis.
• QA & Compliance Consulting Quality assurance services covering GCP/GMP/GLP auditing, pharmacovigilance audits, mock audits, inspection readiness, computer systems validation, SOP development, and CAPA.
• Medical Device Consulting Comprehensive medical device support across clinical study design, regulatory strategy (PMA/510k/CE marking), quality systems (ISO 13485, EU MDR/IVDR), safety surveillance, and HEOR/market access.
• Medical Affairs Consulting Medical affairs strategy and execution including KOL engagement, medical communications, MSL team formation, publication strategy, and evidence generation planning.
• Market Access Consulting Strategic market access and reimbursement services including payer strategy, coverage analysis, pricing strategy, coding assessment, and stakeholder engagement.

Quantifiable outcome

• 98% assignment completion rate
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Scale indicators14 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Allucent: Allucent is a mid-sized CRO specializing in clinical development, regulatory, and post-approval services for small and mid-sized biopharma, with FSP offerings. Similar size, target customer profile, and service mix to BioPoint.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering FSP, full-service clinical, and scientific consulting services across drug development. Like BioPoint, it focuses on mid-tier pharma and biotech clients and emphasizes therapeutic depth and high-touch service—directly comparable in service model and target market.
• Premier Research: Premier Research is a midsized CRO providing clinical development, regulatory affairs, and FSP services to emerging biotech and specialty pharma. Similar to BioPoint, it competes for specialized, mid-complexity engagements where boutique service quality matters more than global scale.
• Rho (a Catapult Company): Rho provides clinical research, regulatory affairs, and HEOR consulting with a strong emphasis on scientific and technical depth, closely overlapping BioPoint's drug safety, regulatory, and HEOR practices. Comparable in client profile (mid-sized pharma and biotech) and service breadth.
• Advanced Clinical: Advanced Clinical is a mid-sized CRO and FSP provider specializing in clinical research, biometrics, and life sciences staffing for pharma and biotech. Similar scale, service mix, and target market to BioPoint, particularly in staff augmentation and FSP engagements.

Broad incumbents

• ICON plc: ICON is one of the largest global CROs with a broad FSP offering across clinical, regulatory, biometrics, and pharmacovigilance. While much larger and more global than BioPoint, ICON directly competes for FSP RFPs from BioPoint's pharma and biotech clients.
• IQVIA: IQVIA is the world's largest CRO and life sciences services firm, offering end-to-end FSP, technology platforms, and consulting across the entire pharma value chain. Comparable in functional service offerings but vastly larger in scale and global footprint.
• Parexel International: Parexel is a global CRO with substantial FSP, regulatory, and clinical operations capabilities serving large pharma. Overlaps with BioPoint in functional service provider engagements for regulatory and drug safety, though with much greater global delivery and technology depth.
• Syneos Health: Syneos Health provides clinical and commercial services including FSP models to pharma and biotech. Now privately held, it competes for similar FSP and functional outsourcing engagements as BioPoint but operates at significantly larger scale with global delivery.
• Kforce Inc. Kforce is a publicly traded professional staffing firm with a dedicated life sciences practice providing contract and direct-hire staffing for pharma, biotech, and medical device clients. Comparable in staffing model and life sciences focus, though broader in scope (technology and finance staffing as well).

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/biopointinc
• Facebookfacebook.com/BioPointinc
• LinkedInlinkedin.com/company/biopoint

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioPoint